Taro Pharmaceuticals To Distribute Pliaglis In The U.S. Crescita Therapeutics has granted Taro Pharmaceuticals an exclusive license to the rights to sell and distribute Pliaglis, a topical anesthetic that sets into a peelable mask, in the U.S. market. The license agreement also includes a second-generation, patent-ending enhanced version of Pliaglis. Crescita will retain all rights to the product in Canada and Mexico. Pliaglis is a topical local anesthetic ( lidocaine 7%/tetracaine 7%) that can be used prior to superficial aesthetic treatments, such as injectables and laser procedures. The product features a proprietary phase-changing topical cream “Peel” technology, which consists of …Read more »
- COMPANY
- INSTITUTE REJUVEE
- CONTINUING EDUCATION
- WORKSHOPS
- RF Q-Polar Training – Institute Rejuvee NY
- RF-Training first level – Institute Rejuvee NY
- Mesotherapy RF Training – Institute Rejuvee NY
- PDT Therapy Training – Institute Rejuvee NY
- Ultrasonic Cavitation Training -Institute Rejuvee NY
- Electrotherapy Training – Institute Rejuvee NY
- RF-Electrocoagulation Training – Institute Rejuvee NY
- Acne Treatment with PDT- Light – workshops
- Cellulite reduce – workshops
- EDUCATION ON-LINE
- TEST ON-LINE
- CONTACT US
- BLOG
Welcome to Institute Rejuvee™
EDUCATION ONLINE, WORKSHOPS, DISTRIBUTION BEAUTY DEVICES